drugset / Trial / NCT00893581

Multimodal Neuroimaging of Treatment Effects in Adolescent Mania

NCT00893581

RandomizedParallel-groupTriple-blindDiagnostic

Summary

Specific Aim 1: To determine the effects of treatment with quetiapine or lithium on brain activation in adolescents. The investigators will use functional magnetic resonance imaging (fMRI) to examine brain activation during an attentional task. Specific Aim 2: To determine the effects of treatment with quetiapine or lithium on neurometabolite measures, early in their illness course. The investigators will use 1H-MRS to identify myo-inositol (mI), N-acetyl aspartate (NAA), and glutamate (Glu) levels in prefrontal ALN regions. Specific Aim 3: To determine the relationships among the changes in brain activation and neurometabolite measures, as well as symptomatic improvement in manic adolescents.

Timeline

Start
2009-03
Primary completion
2016-02
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lithium Unknown 30 mg/kg
Comparator Quetiapine Small molecule 400 mg
Comparator Quetiapine Small molecule 600 mg